Muhammad Waqas Sadiq 1 | Hongtao Yu 2 | Magnus Åstrand 1 | Ian C. Scott 3 | Adam Williams 4 | Lisa Hewitt 5 | Nicholas White 4 | Helen Killick 3 | et....al.2024-09-032024-09-032024-09-03http://98.70.32.231:4000/handle/123456789/1335Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease : British Journal of Clinical PharmacologyArticle